StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BCRX

BioCryst Pharmaceuticals, Inc.

BCRX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$8.81
-0.43 -4.65%

Key statistics

from XBRL data in SEC filings
Market cap
$2.24B
Revenue (TTM)
$886M
Net income (TTM)
-$458M
EPS (TTM)
$-1.77
P/E ratio
Dividend yield
Free cash flow
$345M
Cash
$172M
Total assets
$465M
Gross margin
52-week range
$6.00 – $11.22

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Exit or disposal costs; Regulation FD disclosure Jun 29, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2026 8-K Regulation FD disclosure May 4, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K/A Director or officer change Jan 23, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Jan 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 12, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Other events Dec 12, 2025 8-K Director or officer change Dec 11, 2025 8-K Other events Dec 3, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 3, 2025 8-K Entered a material agreement; Results of operations (earnings release); Director or officer change; Other events Oct 14, 2025 8-K Entered a material agreement; Other events Oct 1, 2025 8-K Director or officer change Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 4, 2025 8-K Director or officer change; Regulation FD disclosure Jul 31, 2025 8-K Director or officer change; Regulation FD disclosure Jul 7, 2025 8-K Entered a material agreement Jun 30, 2025 8-K Other events Jun 27, 2025 8-K Other events Jun 25, 2025 8-K Director or officer change; Shareholder vote results Jun 16, 2025 8-K Director or officer change Jun 4, 2025 8-K Other events May 14, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2025 8-K Director or officer change May 1, 2025 8-K Director or officer change Apr 10, 2025 8-K Other events Mar 11, 2025 8-K Director or officer change Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Feb 24, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 10, 2025 8-K Regulation FD disclosure Jan 8, 2025